{"id":"W6977789187","doi":"10.6084/m9.figshare.c.3603389.v1","title":"HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician’s choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer","year":2016,"lang":"en","type":"other","venue":"Figshare","topic":"Military Technology and Strategies","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Pertuzumab; Trastuzumab; Cardiotoxicity; Breast cancer; Trastuzumab emtansine; Metastatic breast cancer; Chemotherapy; Adjuvant","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002781041,0.002420163,0.002209615,0.0005505972,0.0003772979,0.001248682,0.001303719,0.001882509,0.007179535],"category_scores_gemma":[0.001831788,0.0008952722,0.001859461,0.0003370429,0.001673583,0.001442902,0.0005161837,0.003111071,0.001078947],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001157696,"about_ca_system_score_gemma":0.001609171,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006671444,"about_ca_topic_score_gemma":0.001651601,"domain_scores_codex":[0.9992573,0.000371703,0.00003511042,0.0001615298,0.00004338049,0.0001309639],"domain_scores_gemma":[0.9991853,0.0001697902,0.0001840759,0.00006078203,0.00004549985,0.00035466],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9666699,0.01404052,0.0008427191,0.0005351892,0.0005823055,0.00008823908,0.00008008549,0.000686187,0.005176829,0.0003731465,0.00156051,0.009364277],"study_design_scores_gemma":[0.9211423,0.0754474,0.00103541,0.00003088245,0.0002262202,0.00003182611,0.000022246,0.0003470024,0.0004633624,0.0002053711,0.001032163,0.00001587954],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9736781,0.002986347,0.0008423271,0.001245856,0.00116665,0.01376439,0.001487435,0.0001592794,0.004669522],"genre_scores_gemma":[0.9620467,0.001736216,0.002725549,0.002964041,0.00108461,0.01778546,0.002234487,0.00003254808,0.009390423],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007179535,"threshold_uncertainty_score":0.02401793,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00971696853718982,"score_gpt":0.2675706396932686,"score_spread":0.2578536711560788,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}